Literature DB >> 8041751

Transfection and transient expression of chloramphenicol acetyltransferase gene in the protozoan parasite Entamoeba histolytica.

R Nickel1, E Tannich.   

Abstract

Hybrid plasmids were constructed and used for successful transfection and transient expression of the chloramphenicol acetyltransferase (CAT) gene in the protozoan parasite Entamoeba histolytica. Transfection was performed by electroporation of the amebae in a potassium phosphate-based buffer under conditions of 3000 V/cm and 25 microF, resulting in a time constant of 0.4 ms. Expression of CAT activity was achieved with constructs in which the CAT coding region was flanked by untranslated upstream and downstream sequences of E. histolytica genes. Highest activity was detected after culturing transfected cells for 48 hr. Activity was found to be proportional to the amount of DNA transfected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041751      PMCID: PMC44345          DOI: 10.1073/pnas.91.15.7095

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Electroporation in 'intracellular' buffer increases cell survival.

Authors:  M J van den Hoff; A F Moorman; W H Lamers
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

2.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

3.  Primary structure of the 170-kDa surface lectin of pathogenic Entamoeba histolytica.

Authors:  E Tannich; F Ebert; R D Horstmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  Transfection of Leishmania enriettii and expression of chloramphenicol acetyltransferase gene.

Authors:  A Laban; D F Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 5.  Recent progress in the molecular biology of Entamoeba histolytica.

Authors:  R D Horstmann; M Leippe; E Tannich
Journal:  Trop Med Parasitol       Date:  1992-12

6.  Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii.

Authors:  D Soldati; J C Boothroyd
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

7.  Genomic and cDNA actin sequences from a virulent strain of Entamoeba histolytica.

Authors:  U Edman; I Meza; N Agabian
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Entamoeba histolytica: cloning and characterization of actin cDNA.

Authors:  M Huber; L Garfinkel; C Gitler; D Mirelman; M Revel; S Rozenblatt
Journal:  Mol Biochem Parasitol       Date:  1987-07       Impact factor: 1.759

9.  Expression of a bacterial gene in a trypanosomatid protozoan.

Authors:  V Bellofatto; G A Cross
Journal:  Science       Date:  1989-06-09       Impact factor: 47.728

10.  Transfection of the malaria parasite and expression of firefly luciferase.

Authors:  R Goonewardene; J Daily; D Kaslow; T J Sullivan; P Duffy; R Carter; K Mendis; D Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more
  24 in total

1.  Promoter analysis of palindromic transcription units in the ribosomal DNA circle of Entamoeba histolytica.

Authors:  Sunil K Panigrahi; Gagan Deep Jhingan; Indrani Som; Alok Bhattacharya; William A Petri; Sudha Bhattacharya
Journal:  Eukaryot Cell       Date:  2008-10-31

Review 2.  Regulation of gene expression in protozoa parasites.

Authors:  Consuelo Gomez; M Esther Ramirez; Mercedes Calixto-Galvez; Olivia Medel; Mario A Rodríguez
Journal:  J Biomed Biotechnol       Date:  2010-03-02

3.  The small GTPase EhRabB of Entamoeba histolytica is differentially expressed during phagocytosis.

Authors:  Mario Hernandes-Alejandro; Mercedes Calixto-Gálvez; Israel López-Reyes; Andrés Salas-Casas; Javier Cázares-Ápatiga; Esther Orozco; Mario A Rodríguez
Journal:  Parasitol Res       Date:  2013-02-12       Impact factor: 2.289

4.  Control of ferredoxin and Gal/GalNAc lectin gene expression in Entamoeba histolytica by a cis-acting DNA sequence.

Authors:  C A Gilchrist; B J Mann; W A Petri
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Ubc7/Ube2g2 ortholog in Entamoeba histolytica: connection with the plasma membrane and phagocytosis.

Authors:  Rinki Kumari; Preeti Gupta; Swati Tiwari
Journal:  Parasitol Res       Date:  2018-03-28       Impact factor: 2.289

6.  The abundant polyadenylated transcript 2 DNA sequence of the pathogenic protozoan parasite Entamoeba histolytica represents a nonautonomous non-long-terminal-repeat retrotransposon-like element which is absent in the closely related nonpathogenic species Entamoeba dispar.

Authors:  Ute Willhoeft; Heidrun Buss; Egbert Tannich
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Expression of the nfa1 gene cloned from pathogenic Naegleria fowleri in nonpathogenic N. gruberi enhances cytotoxicity against CHO target cells in vitro.

Authors:  Seok-Ryoul Jeong; Sang-Chul Lee; Kyoung-Ju Song; Sun Park; Kyongmin Kim; Myung-Hee Kwon; Kyung-Il Im; Ho-Joon Shin
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  The 29-kilodalton thiol-dependent peroxidase of Entamoeba histolytica is a factor involved in pathogenesis and survival of the parasite during oxidative stress.

Authors:  Abhik Sen; Nabendu Sekhar Chatterjee; M Ali Akbar; Nilay Nandi; Pradeep Das
Journal:  Eukaryot Cell       Date:  2007-02-16

Review 9.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

10.  Virulence and functions of myosin II are inhibited by overexpression of light meromyosin in Entamoeba histolytica.

Authors:  P Arhets; J C Olivo; P Gounon; P Sansonetti; N Guillén
Journal:  Mol Biol Cell       Date:  1998-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.